Cooper Companies (COO) vs Solventum (SOLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Solventum (SOLV) has outperformed Cooper Companies (COO) over the past year, gaining 19.0% versus a loss of 20.7%. Solventum is the larger company by market cap ($14.57 billion vs $10.23 billion), about 1.4 times the size, while Cooper Companies is growing revenue faster (+5.1% vs +0.9%). On valuation, Cooper Companies trades at a lower forward P/E (11.5x vs 11.8x for Solventum).
Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 9.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COO | SOLV |
|---|---|---|
| Share price | $53.81 | $85.60 |
| Market cap | $10.23B | $14.57B |
| 1-day change | -1.73% | -0.33% |
| YTD return | -33.20% | +8.38% |
| 1-year return | -20.68% | +19.01% |
| 5-year return | -45.02% | — |
| P/E ratio (TTM) | 18.49 | 10.48 |
| Forward P/E | 11.47 | 11.84 |
| EPS (TTM) | $2.91 | $8.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.09B | $8.32B |
| Revenue growth (YoY) | +5.06% | +0.86% |
| Net income (latest FY) | $374.90M | $1.56B |
| Gross margin | 65.54% | 53.47% |
| Operating margin | 16.69% | 26.20% |
| Net margin | 9.16% | 18.69% |
| 52-week high | $89.83 | $94.16 |
| 52-week low | $51.01 | $62.38 |
| Distance from 52-week high | -40.10% | -9.10% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +22.29% | +10.18% |
| Average volume | 3.13M | 1.02M |
| Shares outstanding | 190.16M | 170.22M |
| Employees | 15,000 | 20,584 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SOLV has outperformed COO by 39.7 percentage points over the past year.
- Cooper Companies trades at a higher earnings multiple (18.5x vs 10.5x trailing P/E).
- Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 9.2 cents for Cooper Companies.
About Cooper Companies
COO stock →The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
Health Care · Ophthalmic Goods · 15,000 employees
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
COO vs SOLV FAQ
Which is bigger, Cooper Companies or Solventum?
Solventum (SOLV) is larger, with a market capitalization of $14.57B compared with $10.23B for Cooper Companies (COO).
Which stock has performed better over the past year, COO or SOLV?
SOLV returned +19.01% over the past 12 months, compared with -20.68% for COO (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, COO or SOLV?
SOLV has the lower trailing P/E at 10.5, versus 18.5 for COO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Cooper Companies and Solventum in the same industry?
Both are in the Health Care sector, but in different industries: Ophthalmic Goods for Cooper Companies and Medical/Dental Instruments for Solventum.